More

    COVID-19

    North Korea hit by a killer new fever, Covid19, Emergency Declared

    North Korea reported on Friday that six people who were ill with above normal body temperature have passed away, with one of them testing positive for Covid-19, the official Korean Central News Agency reported as per news agency AFP. "A fever whose cause couldn't be identified explosively spread nationwide from late April… Six persons died (one of them tested positive for the BA.2 sub-variant of...

    Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

    CEPI will provide funding of up to US$19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium comprising Bharat Biotech International Ltd (BBIL), India, the University of Sydney, Australia and ExcellGene SA, Switzerland. Bharat Biotech, University of Sydney and ExcellGene consortium is the latest award that CEPI announced today under its $200 mn programme to advance the development...

    Covid19 Deaths in India – No, WHO is Not Right

    India has objected to WHO report on Covid19 Deaths in India. The World Health Organisation in a report release stated India alone accounted for a third of the total numbers Covid19 deaths. That's not true India says vehemently, stating "WHO has released the excess mortality estimates without adequately addressing India’s concerns.” In its report on excess deaths due to Covid, WHO said that an estimated...

    India Approves COVAXIN for Children 6 to 12 Years Age

    Hyderabad: India has approved COVAXIN for children 6 to 12 years of age today. Bharat Biotech, a global leader in vaccine innovation and developer of vaccines for infectious diseases, announced that BBV152 (COVAXIN), its whole-virion inactivated COVID-19 vaccine candidate, has received emergency use approval in children 6-12 years of age. Covaxin for children facts to know COVAXIN was earlier approved for children 12-18 years of age.Whole-Virion...

    Indian States Has 19.90Cr Unutilised Covid19 Vaccines for Vaccination Now

    COVID19 Vaccines - While, More than 192.85 Crore vaccine doses provided to States/UTs, More than 19.90 Crore balance and unutilized vaccine doses still available with States/UTs, The Ministry of Health and Family Welfare informed on Tuesday. The nationwide COVID-19 vaccination started on 16 January 2021. The new phase of universalization of COVID-19 vaccination commenced on 21 June 2021. India’s Cumulative COVID-19 Vaccination Coverage exceeds 187.95...

    COVAXIN Commercialisation Rights In Mexico Given To Ocugen

    Covaxin Commercialisation rights has been secured by Ocugen Inc. Ocugen and Bharat Biotech has entered into amended agreement to expand the US firm’s Co-development, Supply and Commercialization, and the exclusive territory of commercialisation of Covaxin, a Covid-19 vaccine of the Indian vaccine maker, to Mexico. COVAXIN™️ can be an ideal vaccination option for Mexico at this stage of the pandemic. As a whole virion, inactivated...

    New COVAXIN Price Announced, Rs 225 per dose

    COVAXIN Price is now Rs. 225/- per dose at Private Hospitals. We welcome the decision to make available precautionary dose for all adults. In consultation with the Central Government, we have decided to revise the price of #COVAXIN from Rs 1200 to Rs 225 per dose, for private hospitals, Suchitra Ella the Joint Managing Director of Bharat Biotech Tweeted. Check out the New Covaxin Price...

    Japan to Welcome COVAXIN Jabbed Travelers from April 10, 2022

    COVAXIN Jabbed who were worried to know if Japan will allow entry can now relax as Japan has recognized India`s COVID-19 vaccine COVAXIN manufactured by Bharat Biotech with effect from April 10 to further facilitate travel from India to Japan. The Indian Embassy in Japan on Thursday (April 7) clarified the same. Taking to Twitter, the Embassy wrote, "Government of Japan includes the indigenously...

    Beware of New COVID19 Mutant Strain XE – WHO Warns

    Beware of new Covid19 Mutant Strain XE, WHO has revealed, the 2nd Omicron Recombinant Variant XE has to be in the watch list, this comes after the Omicron, Delta recombinants variant. World Health Organisation (WHO) warned of the 2nd COVID mutant strain XE (hybrid strain of 2 Omicron subvariants) stating that early studies indicate that its growth rate advantage is ~10% as compared to BA.2....

    Say Goodbye to Covid19 Masks in New Delhi, Maharashtra

    COVID19 Masks will now be optional and not mandatory. Indian States, New Delhi and then Maharashtra, which faced the biggest humanitarian crisis due to Covid19, have made Masks optional and people will not be fined if they don't wear their masks in public places. Maharashtra Government will lift all pandemic-related restrictions from Saturday as the state welcomes the Marathi New Year. Meanwhile, the Delhi government...

    Latest Updates

    spot_img